Influenza vaccines to control influenza-associated bacterial infection: where do we stand?

References

• Robinson KM, McHugh KJ, Mandalapu S, et al. Influenza A virus exacerbates Staphylococcus aureus pneumonia in mice by attenuating antimicrobial peptide production. J Infect Dis 2014;209(6):865-75
   PubMedGoogle Scholar
• Finelli L, Fiore A, Dhara R, et al. Influenza-associated pediatric mortality in the United States: increase of Staphylococcus aureus coinfection. Pediatrics 2008;122(4):805-11
   PubMed Web of Science ®Google Scholar
• Nguyen T, Kyle UG, Jaimon N, et al. Coinfection with Staphylococcus aureus increases risk of severe coagulopathy in critically ill children with influenza A (H1N1) virus infection. Crit Care Med 2012;40(12):3246-50
   PubMedGoogle Scholar
• Diavatopoulos DA, Short KR, Price JT, et al. Influenza A virus facilitates Streptococcus pneumoniae transmission and disease. Faseb J 2010;24(6):1789-98
   PubMedGoogle Scholar
• Hausdorff WP, Dagan R, Beckers F, Schuerman L. Estimating the direct impact of new conjugate vaccines against invasive pneumococcal disease. Vaccine 2009;27(52):7257-69
   PubMed Web of Science ®Google Scholar
• Song JH, Dagan R, Klugman KP, Fritzell B. The relationship between pneumococcal serotypes and antibiotic resistance. Vaccine 2012;30(17):2728-37
   PubMedGoogle Scholar
• Robertson L, Caley JP, Moore J. Importance of Staphylococcus aureus in pneumonia in the 1957 epidemic of influenza A. Lancet 1958;2(7040):233-6
   PubMedGoogle Scholar
• van Belkum A, Melles DC, Nouwen J, et al. Co-evolutionary aspects of human colonisation and infection by Staphylococcus aureus. Infect Genet Evol 2009;9(1):32-47
   PubMed Web of Science ®Google Scholar
• Tasher D, Stein M, Simoes EA, et al. Invasive bacterial infections in relation to influenza outbreaks, 2006-2010. Clin Infect Dis 2011;53(12):1199-207
   PubMed Web of Science ®Google Scholar
• Taubenberger JK, Morens DM. 1918;Influenza: the mother of all pandemics. Emerg Infect Dis 2006;12(1):15-22
   Google Scholar
• Worobey M, Han GZ, Rambaut A. Genesis and pathogenesis of the 1918 pandemic H1N1 influenza A virus. Proc Natl Acad Sci USA 2014. [Epub ahead of print]
   PubMedGoogle Scholar
• Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis 2008;198(7):962-70
   PubMed Web of Science ®Google Scholar
• Dauer CC. Mortality in the 1957-58 influenza epidemic. Public Health Rep 1958;73(9):803-10
   PubMedGoogle Scholar
• Martin CM, Kunin CM, Gottlieb LS, Finland M. Asian influenza A in Boston, 1957-1958. II. Severe staphylococcal pneumonia complicating influenza. AMA Arch Intern Med 1959;103(4):532-42
   PubMedGoogle Scholar
• Hers JF, Masurel N, Mulder J. Bacteriology and histopathology of the respiratory tract and lungs in fatal Asian influenza. Lancet 1958;2(7057):1141-3
   PubMedGoogle Scholar
• Burk RF, Schaffner W, Koenig MG. Severe influenza virus pneumonia in the pandemic of 1968-1969. Arch Intern Med 1971;127(6):1122-8
   PubMedGoogle Scholar
• Cilloniz C, Ewig S, Menendez R, et al. Bacterial co-infection with H1N1 infection in patients admitted with community acquired pneumonia. J Infect 2012;65(3):223-30
   PubMedGoogle Scholar
• Estenssoro E, Rios FG, Apezteguia C, et al. Pandemic 2009 influenza A in Argentina: a study of 337 patients on mechanical ventilation. Am J Respir Crit Care Med 2010;182(1):41-8
   PubMed Web of Science ®Google Scholar
• Shieh WJ, Blau DM, Denison AM, et al. 2009 pandemic influenza A (H1N1): pathology and pathogenesis of 100 fatal cases in the United States. Am J Pathol 2010;177(1):166-75
   PubMedGoogle Scholar
• Giannella M, Rodriguez-Sanchez B, Roa PL, et al. Should lower respiratory tract secretions from intensive care patients be systematically screened for influenza virus during the influenza season? Crit Care 2012;16(3):R104
   PubMedGoogle Scholar
• Choi SH, Hong SB, Ko GB, et al. Viral infection in patients with severe pneumonia requiring intensive care unit admission. Am J Respir Crit Care Med 2012;186(4):325-32
   PubMed Web of Science ®Google Scholar
• Walter ND, Taylor TH, Shay DK, et al. Influenza circulation and the burden of invasive pneumococcal pneumonia during a non-pandemic period in the United States. Clin Infect Dis 2010;50(2):175-83
   PubMed Web of Science ®Google Scholar
• Wang XY, Kilgore PE, Lim KA, et al. Influenza and bacterial pathogen coinfections in the 20th century. Interdiscip Perspect Infect Dis 2011;2011:146376
   PubMedGoogle Scholar
• O’Brien L, Donegan N, Flaniken A, et al. Severe coinfection with seasonal influenza A (H3N2) virus and Staphylococcus aureus – Maryland, February-March 2012. MMWR Morb Mortal Wkly Rep 2012;61(16):289-91
   PubMedGoogle Scholar
• Palacios G, Hornig M, Cisterna D, et al. Streptococcus pneumoniae coinfection is correlated with the severity of H1N1 pandemic influenza. PLoS One 2009;4(12):e8540
   PubMed Web of Science ®Google Scholar
• Shaw MW, Xu X, Li Y, et al. Reappearance and global spread of variants of influenza B/Victoria/2/87 lineage viruses in the 2000-2001 and 2001-2002 seasons. Virology 2002;303(1):1-8
   PubMedGoogle Scholar
• McCullers JA, Saito T, Iverson AR. Multiple genotypes of influenza B virus circulated between 1979 and 2003. J Virol 2004;78(23):12817-28
   PubMed Web of Science ®Google Scholar
• Roy T, Agrawal AS, Mukherjee A, et al. Surveillance and molecular characterization of human influenza B viruses during 2006-2010 revealed co-circulation of Yamagata-like and Victoria-like strains in eastern India. Infect Genet Evol 2011;11(7):1595-601
   PubMedGoogle Scholar
• Aebi T, Weisser M, Bucher E, et al. Co-infection of Influenza B and Streptococci causing severe pneumonia and septic shock in healthy women. BMC Infect Dis 2010;10:308
   PubMed Web of Science ®Google Scholar
• Scaber J, Saeed S, Ihekweazu C, et al. Group A streptococcal infections during the seasonal influenza outbreak 2010/11 in South East England. Euro Surveill 2011;16:5
   PubMedGoogle Scholar
• Lam KW, Sin KC, Au SY, Yung SK. Uncommon cause of severe pneumonia: co-infection of influenza B and Streptococcus. Hong Kong Med J 2013;19(6):545-8
   PubMedGoogle Scholar
• Metersky ML, Masterton RG, Lode H, et al. Epidemiology, microbiology, and treatment considerations for bacterial pneumonia complicating influenza. Int J Infect Dis 2012;16(5):e321-31
   PubMed Web of Science ®Google Scholar
• Weinberger DM, Simonsen L, Jordan R, et al. Impact of the 2009 influenza pandemic on pneumococcal pneumonia hospitalizations in the United States. J Infect Dis 2012;205(3):458-65
   PubMed Web of Science ®Google Scholar
• van den Bergh MR, Biesbroek G, Rossen JW, et al. Associations between pathogens in the upper respiratory tract of young children: interplay between viruses and bacteria. PLoS One 2012;7(10):e47711
   Google Scholar
• Randolph AG, Vaughn F, Sullivan R, et al. Critically ill children during the 2009-2010 influenza pandemic in the United States. Pediatrics 2011;128(6):e1450-8
   Google Scholar
• Grijalva CG, Griffin MR, Edwards KM, et al. The role of influenza and parainfluenza infections in nasopharyngeal pneumococcal acquisition among young children. Clin Infect Dis 2014;58(10):1369-76
   PubMed Web of Science ®Google Scholar
• Giebink GS, Ripley ML, Wright PF. Eustachian tube histopathology during experimental influenza A virus infection in the chinchilla. Ann Otol Rhinol Laryngol 1987;96(2 Pt 1):199-206
   PubMedGoogle Scholar
• McCullers JA, McAuley JL, Browall S, et al. Influenza enhances susceptibility to natural acquisition of and disease due to Streptococcus pneumoniae in ferrets. J Infect Dis 2010;202(8):1287-95
   PubMed Web of Science ®Google Scholar
• McCullers JA, Bartmess KC. Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae. J Infect Dis 2003;187(6):1000-9
   PubMed Web of Science ®Google Scholar
• Klugman KP, Astley CM, Lipsitch M. Time from illness onset to death, 1918 influenza and pneumococcal pneumonia. Emerg Infect Dis 2009;15(2):346-7
   PubMedGoogle Scholar
• Gill JR, Sheng ZM, Ely SF, et al. Pulmonary pathologic findings of fatal 2009 pandemic influenza A/H1N1 viral infections. Arch Pathol Lab Med 2010;134(2):235-43
   PubMed Web of Science ®Google Scholar
• Kash JC, Walters KA, Davis AS, et al. Lethal synergism of 2009 pandemic H1N1 influenza virus and Streptococcus pneumoniae coinfection is associated with loss of murine lung repair responses. MBio 2011;2:5
   PubMedGoogle Scholar
• Jamieson AM, Pasman L, Yu S, et al. Role of tissue protection in lethal respiratory viral-bacterial coinfection. Science 2013;340(6137):1230-4
   PubMed Web of Science ®Google Scholar
• Monticelli LA, Sonnenberg GF, Abt MC, et al. Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat Immunol 2011;12(11):1045-54
   PubMed Web of Science ®Google Scholar
• Tong HH, McIver MA, Fisher LM, DeMaria TF. Effect of lacto-N-neotetraose, asialoganglioside-GM1 and neuraminidase on adherence of otitis media-associated serotypes of Streptococcus pneumoniae to chinchilla tracheal epithelium. Microb Pathog 1999;26(2):111-19
   PubMed Web of Science ®Google Scholar
• LaMarco KL, Diven WF, Glew RH. Experimental alteration of chinchilla middle ear mucosae by bacterial neuraminidase. Ann Otol Rhinol Laryngol 1986;95(3 Pt 1):304-8
   PubMedGoogle Scholar
• Linder TE, Lim DJ, DeMaria TF. Changes in the structure of the cell surface carbohydrates of the chinchilla tubotympanum following Streptococcus pneumoniae-induced otitis media. Microb Pathog 1992;13(4):293-303
   PubMedGoogle Scholar
• Peltola VT, Murti KG, McCullers JA. Influenza virus neuraminidase contributes to secondary bacterial pneumonia. J Infect Dis 2005;192(2):249-57
   PubMed Web of Science ®Google Scholar
• Avadhanula V, Rodriguez CA, Devincenzo JP, et al. Respiratory viruses augment the adhesion of bacterial pathogens to respiratory epithelium in a viral species- and cell type-dependent manner. J Virol 2006;80(4):1629-36
   PubMed Web of Science ®Google Scholar
• Huber VC, Peltola V, Iverson AR, McCullers JA. Contribution of vaccine-induced immunity toward either the HA or the NA component of influenza viruses limits secondary bacterial complications. J Virol 2010;84(8):4105-8
   PubMed Web of Science ®Google Scholar
• Siegel SJ, Roche AM, Weiser JN. Influenza Promotes Pneumococcal Growth during Coinfection by Providing Host Sialylated Substrates as a Nutrient Source. Cell Host Microbe 2014;16(1):55-67
   PubMed Web of Science ®Google Scholar
• Chakrabarti AK, Pasricha G. An insight into the PB1F2 protein and its multifunctional role in enhancing the pathogenicity of the influenza A viruses. Virology 2013;440(2):97-104
   PubMedGoogle Scholar
• McAuley JL, Chipuk JE, Boyd KL, et al. PB1-F2 proteins from H5N1 and 20 century pandemic influenza viruses cause immunopathology. PLoS Pathog 2010;6(7):e1001014
   PubMed Web of Science ®Google Scholar
• Alymova IV, Samarasinghe A, Vogel P, et al. A novel cytotoxic sequence contributes to influenza A viral protein PB1-F2 pathogenicity and predisposition to secondary bacterial infection. J Virol 2014;88(1):503-15
   PubMedGoogle Scholar
• Chen W, Calvo PA, Malide D, et al. A novel influenza A virus mitochondrial protein that induces cell death. Nat Med 2001;7(12):1306-12
   PubMed Web of Science ®Google Scholar
• Smith AM, Adler FR, Ribeiro RM, et al. Kinetics of coinfection with influenza A virus and Streptococcus pneumoniae. PLoS Pathog 2013;9(3):e1003238
   PubMed Web of Science ®Google Scholar
• Ghoneim HE, Thomas PG, McCullers JA. Depletion of alveolar macrophages during influenza infection facilitates bacterial superinfections. J Immunol 2013;191(3):1250-9
   PubMed Web of Science ®Google Scholar
• Bordon J, Aliberti S, Fernandez-Botran R, et al. Understanding the roles of cytokines and neutrophil activity and neutrophil apoptosis in the protective versus deleterious inflammatory response in pneumonia. Int J Infect Dis 2013;17(2):e76-83
   PubMed Web of Science ®Google Scholar
• Didierlaurent A, Goulding J, Patel S, et al. Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infection. J Exp Med 2008;205(2):323-9
   PubMed Web of Science ®Google Scholar
• Sun K, Metzger DW. Inhibition of pulmonary antibacterial defense by interferon-gamma during recovery from influenza infection. Nat Med 2008;14(5):558-64
   PubMed Web of Science ®Google Scholar
• Goulding J, Godlee A, Vekaria S, et al. Lowering the threshold of lung innate immune cell activation alters susceptibility to secondary bacterial superinfection. J Infect Dis 2011;204(7):1086-94
   PubMed Web of Science ®Google Scholar
• McNamee LA, Harmsen AG. Both influenza-induced neutrophil dysfunction and neutrophil-independent mechanisms contribute to increased susceptibility to a secondary Streptococcus pneumoniae infection. Infect Immun 2006;74(12):6707-21
   PubMed Web of Science ®Google Scholar
• Medeiros AI, Serezani CH, Lee SP, Peters-Golden M. Efferocytosis impairs pulmonary macrophage and lung antibacterial function via PGE2/EP2 signaling. J Exp Med 2009;206(1):61-8
   PubMed Web of Science ®Google Scholar
• Garcia-Sastre A. Induction and evasion of type I interferon responses by influenza viruses. Virus Res 2011;162(1-2):12-18
   PubMed Web of Science ®Google Scholar
• Nakamura S, Davis KM, Weiser JN. Synergistic stimulation of type I interferons during influenza virus coinfection promotes Streptococcus pneumoniae colonization in mice. J Clin Invest 2011;121(9):3657-65
   PubMed Web of Science ®Google Scholar
• Shahangian A, Chow EK, Tian X, et al. Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice. J Clin Invest 2009;119(7):1910-20
   PubMed Web of Science ®Google Scholar
• Li W, Moltedo B, Moran TM. Type I interferon induction during influenza virus infection increases susceptibility to secondary Streptococcus pneumoniae infection by negative regulation of gammadelta T cells. J Virol 2012;86(22):12304-12
   PubMed Web of Science ®Google Scholar
• Serre K, Silva-Santos B. Molecular mechanisms of differentiation of murine pro-inflammatory gammadelta T cell subsets. Front Immunol 2013;4:431
   PubMedGoogle Scholar
• Kudva A, Scheller EV, Robinson KM, et al. Influenza A inhibits Th17-mediated host defense against bacterial pneumonia in mice. J Immunol 2011;186(3):1666-74
   PubMed Web of Science ®Google Scholar
• Ivanov S, Renneson J, Fontaine J, et al. Interleukin-22 reduces lung inflammation during influenza A virus infection and protects against secondary bacterial infection. J Virol 2013;87(12):6911-24
   PubMedGoogle Scholar
• Cao J, Wang D, Xu F, et al. Activation of IL-27 signalling promotes development of postinfluenza pneumococcal pneumonia. EMBO Mol Med 2014;6(1):120-40
   PubMedGoogle Scholar
• Diveu C, McGeachy MJ, Boniface K, et al. IL-27 blocks RORc expression to inhibit lineage commitment of Th17 cells. J Immunol 2009;182(9):5748-56
   PubMed Web of Science ®Google Scholar
• Moffitt KL, Malley R, Lu YJ. Identification of protective pneumococcal T(H)17 antigens from the soluble fraction of a killed whole cell vaccine. PLoS One 2012;7(8):e43445
   PubMed Web of Science ®Google Scholar
• Moffitt K, Skoberne M, Howard A, et al. Toll-like receptor 2-dependent protection against pneumococcal carriage by immunization with lipidated pneumococcal proteins. Infect Immun 2014;82(5):2079-86
   PubMed Web of Science ®Google Scholar
• Allard R, Couillard M, Pilon P, et al. Invasive bacterial infections following influenza: a time-series analysis in Montreal, Canada, 1996-2008. Influenza Other Respir Viruses 2012;6(4):268-75
   PubMedGoogle Scholar
• Mehr S, Wood N. Streptococcus pneumoniae--a review of carriage, infection, serotype replacement and vaccination. Paediatr Respir Rev 2012;13(4):258-64
   PubMedGoogle Scholar
• Feldman C, Anderson R. Review: current and new generation pneumococcal vaccines. J Infect 2014. [Epub ahead of print]
   PubMedGoogle Scholar
• Hak E, Grobbee DE, Sanders EA, et al. Rationale and design of CAPITA: a RCT of 13-valent conjugated pneumococcal vaccine efficacy among older adults. Neth J Med 2008;66(9):378-83
   PubMed Web of Science ®Google Scholar
• Jackson LA, Janoff EN. Pneumococcal vaccination of elderly adults: new paradigms for protection. Clin Infect Dis 2008;47(10):1328-38
   PubMed Web of Science ®Google Scholar
• Kuster SP, Tuite AR, Kwong JC, et al. Evaluation of coseasonality of influenza and invasive pneumococcal disease: results from prospective surveillance. PLoS Med 2011;8(6):e1001042
   Google Scholar
• Chang YC, Chou YJ, Liu JY, et al. Additive benefits of pneumococcal and influenza vaccines among elderly persons aged 75 years or older in Taiwan--a representative population-based comparative study. J Infect 2012;65(3):231-8
   PubMed Web of Science ®Google Scholar
• Furumoto A, Ohkusa Y, Chen M, et al. Additive effect of pneumococcal vaccine and influenza vaccine on acute exacerbation in patients with chronic lung disease. Vaccine 2008;26(33):4284-9
   PubMed Web of Science ®Google Scholar
• Sumitani M, Tochino Y, Kamimori T, et al. Additive inoculation of influenza vaccine and 23-valent pneumococcal polysaccharide vaccine to prevent lower respiratory tract infections in chronic respiratory disease patients. Intern Med 2008;47(13):1189-97
   PubMedGoogle Scholar
• Nichol KL. The additive benefits of influenza and pneumococcal vaccinations during influenza seasons among elderly persons with chronic lung disease. Vaccine 1999;17(Suppl 1):S91-3
   PubMedGoogle Scholar
• Christenson B, Hedlund J, Lundbergh P, Ortqvist A. Additive preventive effect of influenza and pneumococcal vaccines in elderly persons. Eur Respir J 2004;23(3):363-8
   PubMed Web of Science ®Google Scholar
• Gilchrist SA, Nanni A, Levine O. Benefits and effectiveness of administering pneumococcal polysaccharide vaccine with seasonal influenza vaccine: an approach for policymakers. Am J Public Health 2012;102(4):596-605
   PubMed Web of Science ®Google Scholar
• Christenson B, Pauksen K, Sylvan SP. Effect of influenza and pneumococcal vaccines in elderly persons in years of low influenza activity. Virol J 2008;5:52
   PubMed Web of Science ®Google Scholar
• Dominguez A, Castilla J, Godoy P, et al. Effectiveness of vaccination with 23-valent pneumococcal polysaccharide vaccine in preventing hospitalization with laboratory confirmed influenza during the 2009-2010 and 2010-2011 seasons. Hum Vaccin Immunother 2013;9(4):865-73
   PubMed Web of Science ®Google Scholar
• Vila-Corcoles A, Ochoa-Gondar O, Hospital I, et al. Protective effects of the 23-valent pneumococcal polysaccharide vaccine in the elderly population: the EVAN-65 study. Clin Infect Dis 2006;43(7):860-8
   PubMed Web of Science ®Google Scholar
• Mahamat A, Daures JP, de Wzieres B. Additive preventive effect of influenza and pneumococcal vaccines in the elderly: results of a large cohort study. Hum Vaccin Immunother 2013;9(1):128-35
   PubMed Web of Science ®Google Scholar
• Jefferson T, Di Pietrantonj C, Al-Ansary LA, et al. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev 2010(2):CD004876
   PubMed Web of Science ®Google Scholar
• Nelson JC, Jackson ML, Weiss NS, Jackson LA. New strategies are needed to improve the accuracy of influenza vaccine effectiveness estimates among seniors. J Clin Epidemiol 2009;62(7):687-94
   PubMed Web of Science ®Google Scholar
• Nelson JC, Marsh T, Lumley T, et al. Validation sampling can reduce bias in health care database studies: an illustration using influenza vaccination effectiveness. J Clin Epidemiol 2013;66(8 Suppl):S110-21
   Google Scholar
• Simonsen L, Taylor RJ, Viboud C, et al. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis 2007;7(10):658-66
   PubMed Web of Science ®Google Scholar
• Beyer WE, McElhaney J, Smith DJ, et al. Cochrane re-arranged: support for policies to vaccinate elderly people against influenza. Vaccine 2013;31(50):6030-3
   PubMed Web of Science ®Google Scholar
• McGarry LJ, Gilmore KE, Rubin JL, et al. Impact of 13-valent pneumococcal conjugate vaccine (PCV13) in a pandemic similar to the 2009 H1N1 in the United States. BMC Infect Dis 2013;13:229
   PubMedGoogle Scholar
• Simonsen L, Taylor RJ, Young-Xu Y, et al. Impact of pneumococcal conjugate vaccination of infants on pneumonia and influenza hospitalization and mortality in all age groups in the United States. MBio 2011;2(1):e00309-10
   PubMed Web of Science ®Google Scholar
• De Wals P, Robin E, Fortin E, et al. Pneumonia after implementation of the pneumococcal conjugate vaccine program in the province of Quebec. Canada. Pediatr Infect Dis J 2008;27(11):963-8
   PubMedGoogle Scholar
• Jardine A, Menzies RI, McIntyre PB. Reduction in hospitalizations for pneumonia associated with the introduction of a pneumococcal conjugate vaccination schedule without a booster dose in Australia. Pediatr Infect Dis J 2010;29(7):607-12
   PubMedGoogle Scholar
• Madhi SA, Klugman KP. A role for Streptococcus pneumoniae in virus-associated pneumonia. Nat Med 2004;10(8):811-13
   PubMed Web of Science ®Google Scholar
• Ozgur SK, Beyazova U, Kemaloglu YK, et al. Effectiveness of inactivated influenza vaccine for prevention of otitis media in children. Pediatr Infect Dis J 2006;25(5):401-4
   PubMedGoogle Scholar
• Heikkinen T, Ruuskanen O, Waris M, et al. Influenza vaccination in the prevention of acute otitis media in children. Am J Dis Child 1991;145(4):445-8
   PubMedGoogle Scholar
• Clements DA, Langdon L, Bland C, Walter E. Influenza A vaccine decreases the incidence of otitis media in 6- to 30-month-old children in day care. Arch Pediatr Adolesc Med 1995;149(10):1113-17
   PubMedGoogle Scholar
• Marchisio P, Cavagna R, Maspes B, et al. Efficacy of intranasal virosomal influenza vaccine in the prevention of recurrent acute otitis media in children. Clin Infect Dis 2002;35(2):168-74
   PubMedGoogle Scholar
• Heikkinen T, Block SL, Toback SL, et al. Effectiveness of intranasal live attenuated influenza vaccine against all-cause acute otitis media in children. Pediatr Infect Dis J 2013;32(6):669-74
   PubMedGoogle Scholar
• Lee SE, Eick A, Bloom MS, Brundage JF. Influenza immunization and subsequent diagnoses of group A streptococcus-illnesses among U.S. Army trainees, 2002-2006. Vaccine 2008;26(27-28):3383-6
   PubMed Web of Science ®Google Scholar
• Skerrett SJ. Diagnostic testing for community-acquired pneumonia. Clin Chest Med 1999;20(3):531-48
   PubMedGoogle Scholar
• Klugman KP, Chien YW, Madhi SA. Pneumococcal pneumonia and influenza: a deadly combination. Vaccine 2009;27(Suppl 3):C9-C14
   Google Scholar
• Waterer GW, Wunderink RG. The influence of the severity of community-acquired pneumonia on the usefulness of blood cultures. Respir Med 2001;95(1):78-82
   PubMedGoogle Scholar
• Mina MJ, McCullers JA, Klugman KP. Live attenuated influenza vaccine enhances colonization of Streptococcus pneumoniae and Staphylococcus aureus in mice. MBio 2014;5:1
   Web of Science ®Google Scholar
• Mina MJ, Klugman KP, McCullers JA. Live attenuated influenza vaccine, but not pneumococcal conjugate vaccine, protects against increased density and duration of pneumococcal carriage after influenza infection in pneumococcal colonized mice. J Infect Dis 2013;208(8):1281-5
   PubMedGoogle Scholar
• Sun K, Ye J, Perez DR, Metzger DW. Seasonal FluMist vaccination induces cross-reactive T cell immunity against H1N1 (2009) influenza and secondary bacterial infections. J Immunol 2011;186(2):987-93
   PubMed Web of Science ®Google Scholar